Filters
Other countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
GJA5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 239 | 100 |
|
Invitae Arrhythmia Comprehensive Panel Invitae United States | 115 | 41 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Congenital structural heart disease panel. NGS panel of 62 genes. Genologica Medica Spain | 113 | 62 |
|
Atrial standstill: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 3 |
|
GJA5 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Structural Heart Disease NGS Panel Fulgent Genetics United States | 73 | 28 |
|
Cardiac Conduction System Related Disorders , Panel Massive Sequencing (NGS) 20 Genes Reference Laboratory Genetics Spain | 26 | 20 |
|
Asper Biogene Asper Biogene LLC Estonia | 66 | 38 |
|
Cardio-channelopathy-gene-panel MVZ Dr. Eberhard & Partner Dortmund Germany | 35 | 33 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Sudden Death Syndrome NGS Panel Fulgent Genetics United States | 168 | 68 |
|
Fulgent Genetics United States | 67 | 24 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 671 | 250 |
|
Comprehensive Arrhythmia NGS Panel Fulgent Genetics United States | 184 | 76 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.